Skip to content

The AMD Experts

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to turn their practice into an AMD Center of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

By being able to test more patients, we’ll ultimately uncover more macular degeneration. That’s good for patients. And I think we all need to realize that what’s good for our patients winds up being good for our practices.

Jeffry D. Gerson, OD, FAAO Jeffry Gerson, OD, FAAO View all testimonials

Latest News & Upcoming Events

View More
Our Blog: June 6, 2021

5 Things I’ve Learned About Dark Adaptation Testing in My First Year

Integrating new technology into your practice can be a challenge, but Theia is here to share some secrets that can lead to success.

Article: May 19, 2021 | IoT Times

6 Ways IoT Tech is Changing the Medical Field

The Internet of Things (IoT) accelerates medical advancements, bringing much-appreciated improvements for patients and providers alike. Here are six ways in which IoT technology, such as the AdaptDx Pro guided by Theia, has recently benefited the medical field.

Article: May 19, 2021 | Review of Optometric Business

A New Approach to the Old Problem of AMD

Plenty can change in the months between comprehensive exams, especially for our aging patients. Dr. Tammy Tully sleeps better at night knowing that she's detecting AMD as early as possible to prescribe proactive treatment to help preserve their vision.

Put Our Expertise to Work

Testing with AdaptDx Pro

AdaptDx Pro identifies impaired dark adaptation—the earliest warning sign of AMD.

Implementation Expertise

Each AdaptDx Pro purchase is supported by our AMD Excellence Program® to help you achieve your patient care and practice revenue goals.